165 related articles for article (PubMed ID: 12650488)
21. Influence of time of day on propofol pharmacokinetics and pharmacodynamics in rabbits.
Bienert A; Płotek W; Zawidzka I; Ratajczak N; Szczesny D; Wiczling P; Kokot ZJ; Matysiak J; Grześkowiak E
Chronobiol Int; 2011 May; 28(4):318-29. PubMed ID: 21539423
[TBL] [Abstract][Full Text] [Related]
22. Development of acute tolerance to the EEG effect of propofol in rats.
Ihmsen H; Schywalsky M; Tzabazis A; Schwilden H
Br J Anaesth; 2005 Sep; 95(3):367-71. PubMed ID: 15980043
[TBL] [Abstract][Full Text] [Related]
23. Efficacy comparison of the novel water-soluble propofol prodrug HX0969w and fospropofol in mice and rats.
Zhou Y; Yang J; Liu J; Wang Y; Zhang WS
Br J Anaesth; 2013 Nov; 111(5):825-32. PubMed ID: 23801745
[TBL] [Abstract][Full Text] [Related]
24. Influence of formulation on propofol pharmacokinetics and pharmacodynamics in anesthetized patients.
Calvo R; Telletxea S; Leal N; Aguilera L; Suarez E; De La Fuente L; Martin-Suarez A; Lukas JC
Acta Anaesthesiol Scand; 2004 Sep; 48(8):1038-48. PubMed ID: 15315624
[TBL] [Abstract][Full Text] [Related]
25. Population pharmacokinetics of propofol: a multicenter study.
Schüttler J; Ihmsen H
Anesthesiology; 2000 Mar; 92(3):727-38. PubMed ID: 10719952
[TBL] [Abstract][Full Text] [Related]
26. Formulation-dependent pharmacokinetics and pharmacodynamics of propofol in rats.
Dutta S; Ebling WF
J Pharm Pharmacol; 1998 Jan; 50(1):37-42. PubMed ID: 9504432
[TBL] [Abstract][Full Text] [Related]
27. Assessing circadian rhythms in propofol PK and PD during prolonged infusion in ICU patients.
Bienert A; Kusza K; Wawrzyniak K; Grześkowiak E; Kokot ZJ; Matysiak J; Grabowski T; Wolc A; Wiczling P; Regulski M
J Pharmacokinet Pharmacodyn; 2010 Jun; 37(3):289-304. PubMed ID: 20544262
[TBL] [Abstract][Full Text] [Related]
28. Influence of demographic factors, basic blood test parameters and opioid type on propofol pharmacokinetics and pharmacodynamics in ASA I-III patients.
Bienert A; Wiczling P; Zaba C; Zaba Z; Wolc A; Marciniak R; Grześkowiak E; Kusza K
Arzneimittelforschung; 2011; 61(10):545-52. PubMed ID: 22164962
[TBL] [Abstract][Full Text] [Related]
29. The influence of hemorrhagic shock on propofol: a pharmacokinetic and pharmacodynamic analysis.
Johnson KB; Egan TD; Kern SE; White JL; McJames SW; Syroid N; Whiddon D; Church T
Anesthesiology; 2003 Aug; 99(2):409-20. PubMed ID: 12883414
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics and pharmacodynamics of propofol in patients undergoing abdominal aortic surgery.
Wiczling P; Bienert A; Sobczyński P; Hartmann-Sobczyńska R; Bieda K; Marcinkowska A; Malatyńska M; Kaliszan R; Grześkowiak E
Pharmacol Rep; 2012; 64(1):113-22. PubMed ID: 22580527
[TBL] [Abstract][Full Text] [Related]
31. Propofol pharmacokinetics and pharmacodynamics assessed from a cremophor EL formulation.
Dutta S; Matsumoto Y; Ebling WF
J Pharm Sci; 1997 Aug; 86(8):967-9. PubMed ID: 9269876
[No Abstract] [Full Text] [Related]
32. Optimization of initial propofol bolus dose for EEG Narcotrend Index-guided transition from sevoflurane induction to intravenous anesthesia in children.
Dennhardt N; Boethig D; Beck C; Heiderich S; Boehne M; Leffler A; Schultz B; Sümpelmann R
Paediatr Anaesth; 2017 Apr; 27(4):425-432. PubMed ID: 28213945
[TBL] [Abstract][Full Text] [Related]
33. The pharmacokinetics and pharmacodynamics of propofol in a modified cyclodextrin formulation (Captisol) versus propofol in a lipid formulation (Diprivan): an electroencephalographic and hemodynamic study in a porcine model.
Egan TD; Kern SE; Johnson KB; Pace NL
Anesth Analg; 2003 Jul; 97(1):72-9, table of contents. PubMed ID: 12818946
[TBL] [Abstract][Full Text] [Related]
34. Effects of parecoxib, a parenteral COX-2-specific inhibitor, on the pharmacokinetics and pharmacodynamics of propofol.
Ibrahim A; Park S; Feldman J; Karim A; Kharasch ED
Anesthesiology; 2002 Jan; 96(1):88-95. PubMed ID: 11753007
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics and pharmacodynamics of propofol in children undergoing different types of surgeries.
Bartkowska-Śniatkowska A; Bienert A; Wiczling P; Owczarek M; Rosada-Kurasińska J; Grześkowiak M; Matysiak J; Kokot ZJ; Kaliszan R; Grześkowiak E
Pharmacol Rep; 2014 Oct; 66(5):821-9. PubMed ID: 25149986
[TBL] [Abstract][Full Text] [Related]
36. Do epoch lengths of hypnotic depth indicators affect estimated of blood-brain equilibration rate constants of propofol?
Kim KM; Park S; Kang BJ; Choi BM; Noh GJ; Bang JY
J Pharmacokinet Pharmacodyn; 2021 Apr; 48(2):305-317. PubMed ID: 33415524
[TBL] [Abstract][Full Text] [Related]
37. The influence of age and administration rate on the brain sensitivity to propofol in rats.
Larsson JE; Wahlström G
Acta Anaesthesiol Scand; 1998 Sep; 42(8):987-94. PubMed ID: 9773145
[TBL] [Abstract][Full Text] [Related]
38. Morbid Obesity Alters Both Pharmacokinetics and Pharmacodynamics of Propofol: Dosing Recommendation for Anesthesia Induction.
Dong D; Peng X; Liu J; Qian H; Li J; Wu B
Drug Metab Dispos; 2016 Oct; 44(10):1579-83. PubMed ID: 27481855
[TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics of a single bolus of propofol in chinese children of different ages.
Shangguan WN; Lian Q; Aarons L; Matthews I; Wang Z; Chen X; Freemantle N; Smith FG
Anesthesiology; 2006 Jan; 104(1):27-32. PubMed ID: 16394686
[TBL] [Abstract][Full Text] [Related]
40. Bispectral index dynamics during propofol hypnosis is similar in red-haired and dark-haired subjects.
Doufas AG; Orhan-Sungur M; Komatsu R; Lauber R; Akca O; Shafer SL; Sessler DI
Anesth Analg; 2013 Feb; 116(2):319-26. PubMed ID: 23302977
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
